title: Prostate cancer: results of external irradiation.
abstract: From 1975 to 1982, 205 patients with local prostate cancer were treated at the radiation oncology department, the University of Kansas Medical Center, Kansas City, Kansas. Patients' median age was 73 years. All of the patients were staged according to American Urologic staging criteria. Twenty-eight patients had stage A2 cancer, 91 patients had stage B cancer, and 86 patients had stage C cancer. All patients were treated using megavoltage radiation (dosage range: 6000 cGy to 7100 cGy). The follow-up period ranged from a minimum of 8 years to a maximum of 15 years (median: 9.4 years). The clinical local control was 96% for stage A2, 94% for stage B, and 90% for stage C disease. The overall and disease-free survival rates were 71% and 60%, respectively. Fourteen patients developed moderate complications with one patient (0.5%) requiring surgical intervention. The local control and survival rates reported in this study are comparable with surgical results, suggesting that external beam irradiation in prostate cancer is safe and effective.
authors.affiliation: Department of Radiation Oncology, University of Kansas Medical Center, Kansas City.
authors.forename: E K
authors.initials: EK
authors.lastname: Reddy
authors.forename: L
authors.initials: L
authors.lastname: Krishnan
authors.forename: S
authors.initials: S
authors.lastname: Giri
authors.forename: R G
authors.initials: RG
authors.lastname: Evans
authors.forename: W K
authors.initials: WK
authors.lastname: Mebust
authors.forename: J W
authors.initials: JW
authors.lastname: Weigel
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D011882:Radiotherapy, High-Energy; D015996:Survival Rate